# Neurocrine Biosciences (NBIX) — Analyst Forecast

NBIX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/nbix/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | BMO Capital | Maintained | Market Perform | $150.00 |
| Oct 6, 2026 | Guggenheim | Initiated Coverage | Buy | $207.00 |
| Sep 29, 2026 | UBS | Maintained | Buy | $214.00 |
| Sep 11, 2026 | Morgan Stanley | Maintained | Equal-Weight | $183.00 |
| Sep 8, 2026 | RBC Capital | Maintained | Outperform | $198.00 |
| Sep 3, 2026 | Citigroup | Maintained | Buy | $253.00 |
| Aug 13, 2026 | Morgan Stanley | Maintained | Equal-Weight | $182.00 |
| Aug 3, 2026 | Wedbush | Maintained | Outperform | $194.00 |
| Aug 3, 2026 | Truist Securities | Maintained | Buy | $213.00 |
| Aug 3, 2026 | Canaccord Genuity | Maintained | Buy | $210.00 |
| Jul 31, 2026 | Needham | Maintained | Buy | $204.00 |
| Jul 31, 2026 | Stifel | Maintained | Buy | $215.00 |
| Jul 31, 2026 | Guggenheim | Maintained | Buy | $222.00 |
| Jul 31, 2026 | Piper Sandler | Maintained | Overweight | $210.00 |
| Jul 31, 2026 | Cantor Fitzgerald | Maintained | Overweight | $215.00 |
| Jul 31, 2026 | TD Cowen | Maintained | Buy | $220.00 |
| Jul 31, 2026 | Morgan Stanley | Maintained | Equal-Weight | $196.00 |
| Jul 31, 2026 | RBC Capital | Maintained | Outperform | $198.00 |
| Jul 31, 2026 | Citigroup | Maintained | Buy | $249.00 |
| Jul 21, 2026 | Guggenheim | Maintained | Buy | $200.00 |

## Frequently Asked Questions

### What is the latest analyst rating on NBIX?

On Oct 12, 2026, BMO Capital maintained Neurocrine Biosciences at Market Perform with a price target of $150.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).